Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101

NCT03644459 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Unable to recruit individuals for the study

Conditions

Ovarian Cancer
Cervical Cancer
Colorectal Cancer
Stomach Cancer

Interventions

BIOLOGICAL: LYN00101

Sponsor

Lynkcell Inc.